Portal Hypertension Special Interest Group
The Portal Hypertension Special Interest Group (SIG) was established to facilitate collaborations in clinical and translational research, and to provide a platform to nurture discussion in best management of patients in this complex and rapidly evolving area. The SIG is linked to Cirrhosis and its Complications CRN topic area.
Portal Hypertension is a very active research area, with recent NIHR HTA funding of two randomised controlled trials which have the potential to become the largest ever clinical trials in cirrhosis. Translational research has been boosted by studies on non-invasive assessment of Portal Hypertension, and exciting new drugs. There is also much debate on the best management of patients with regard to medical and radiological therapies. The SIG Lead is Dr Dhiraj Tripathi of University Hospitals Birmingham. If anyone wishes to join this group please contact Samantha@basl.org.uk.
Dr Dhiraj Tripathi (Chair), University Hospitals Birmingham
Professor Jonathan Fallowfield, University of Edinburgh
Professor Peter Hayes, University of Edinburgh
Dr Joanna Leithead, Addenbrookes Hospital, Cambridge
Dr Raj Mookerjee, University College London
Dr David Patch, University College London
Dr Vikram Sharma, Royal London Hospital
Professor Adrian Stanley, Glasgow Royal Infirmary
Dr Emmanouil Tsochatzis, University College London
1st Steering Committee meeting - 7 November 2018
Further resources to be added.
The first teleconference of the Portal Hypertension SIG took place on Wednesday 7th November 2018. Download BASL Portal Hypertension SIG Steering Committee Teleconference Minutes- 7 Nov 2018.pdf.
The inaugural meeting of the BASL Portal Hypertension SIG is planned for spring 2019. Further details to follow.